Norihisa Shigemura, MD, Jonathan D'Cunha, MD, Jay K

Slides:



Advertisements
Similar presentations
Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.
Advertisements

De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation 
What Predicts Long-Term Survival After Heart Transplantation
Elizabeth A. David, MD, David T
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Benny Weksler, MD, Jennifer L. Sullivan, MD 
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S
Ramiro Fernandez, MD, Amy Ratliff, MD, Donna Crabb, MT, Ken B
Postoperative Swallowing Assessment After Lung Transplantation
Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer  Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,
Double-Lung Transplantation Can Be Safely Performed Using Donors With Heavy Smoking History  Sharven Taghavi, MD, MPH, Senthil Jayarajan, MD, Eugene Komaroff,
Amr Mohammad Allama, MD  The Annals of Thoracic Surgery 
Richard K. Freeman, MD, Anthony J. Ascioti, MD, Jaclyn M
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation  Don Hayes, MD, MS, Sylvester M. Black,
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease  Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,
Michael Eberlein, MD, PhD, Robert M
Takushi Kohmoto, MD, PhD, Satoru Osaki, MD, PhD, Dixon B
The Annals of Thoracic Surgery
Survival of Patients With or Without Symptoms Undergoing Potentially Curative Resections for Primary Lung Cancer  Andrea R.G. Sheel, BS (Hons), MBChB,
Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival  Daniel L. Miller, MD, William R. Mayfield, MD,
Katy A. Marino, MD, Jennifer L. Sullivan, MD, Benny Weksler, MD 
Long-term patient and allograft outcomes of renal transplant recipients undergoing cardiac surgery  Rodolfo V. Rocha, MD, Diana Zaldonis, MPH, Vinay Badhwar,
Outcomes of Intraoperative Venoarterial Extracorporeal Membrane Oxygenation Versus Cardiopulmonary Bypass During Lung Transplantation  Christian A. Bermudez,
Origins of the Cardiothoracic Surgery Network (CTSNet)
Who Do You Say You Are? The Annals of Thoracic Surgery
Bryan A. Whitson, MD, PhD, Marshall I. Hertz, MD, Rosemary F
Saving Lives Is More Important Than Abstract Moral Concerns: Financial Incentives Should Be Used to Increase Organ Donation  Benjamin Hippen, MD, Lainie.
Use of Amiodarone After Major Lung Resection
Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma
Extracorporeal Membrane Oxygenation for Advanced Refractory Shock in Acute and Chronic Cardiomyopathy  Christian A. Bermudez, MD, Rodolfo V. Rocha, MD,
Outcomes and Costs for Major Lung Resection in the United States: Which Patients Benefit Most From High-Volume Referral?  Elliot Wakeam, MD, MPH, Joseph.
Joseph Rabin, MD, Timothy Meyenburg, DNP, CRNP, Ashleigh V
Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer  Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,
Lung Function and ECMO After Lung Transplantation
A first start for lung transplantation?
Acute Kidney Injury Increases Mortality After Lung Transplantation
Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A
Raheel Rizwan, MD, Farhan Zafar, MD, Roosevelt Bryant, MD, James S
Is Nocturnal Extubation After Cardiac Surgery Associated With Worse Outcomes?  Murtaza Diwan, MD, Jeremy Wolverton, MS, Bo Yang, MD, Jonathan Haft, MD,
Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty
The ripple effect of a complication in lung transplantation: Evidence for increased long- term survival risk  Ernest G. Chan, MD, Valentino Bianco, DO,
Editorial Board, January 2010
William M. Whited, MD, Paul Henley, BS, Erin M
Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor
Roni M. Jacobsen, MD, Michael G. Earing, MD, Garick D
Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L
Single Versus Double Lung Retransplantation Does Not Affect Survival Based on Previous Transplant Type  Erin M. Schumer, MD, MPH, Jonathan D. Rice, MD,
Lung Transplant, Double Valve Repair, and Pulmonary Artery Aneurysm Resection  Hossein Shayan, MD, Basar Sareyyupoglu, MD, Norihisa Shigemura, MD, Jnanesh.
The Annals of Thoracic Surgery
Postesophagectomy Chylothorax: Incidence, Risk Factors, and Outcomes
David P. Mason, MD, Chase R. Brown, BS, Sudish C
Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer?  Anna Lee, MD, MPH, Andrew T.
Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer  Pamela Samson, MD,
Scott B. Johnson, MD, Anna M. Allred, BS, Adam M. Cline, MD, Luis F
Sharven Taghavi, MD, MPH, Senthil N
“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:
Pitfalls in donor lung procurements: How should the procedure be taught to transplant trainees?  Norihisa Shigemura, MD, Jay Bhama, MD, Duc Nguyen, MD,
Christian A. Bermudez, MD, Rodolfo V
Are There Enough Jobs in Cardiothoracic Surgery
Mark I. Block, MD  The Annals of Thoracic Surgery 
Lobectomy Versus Limited Resection in T1N0 Lung Cancer
Aortic Valve Replacement Surgery: Comparison of Outcomes in Matched Sternotomy and PORT ACCESS Groups  William T. Brinkman, MD, William Hoffman, MD, Todd.
The Impact of New Technology on Cardiothoracic Surgical Practice
Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support  Peter B. Manning, MD, Michael J. Rutter, MD,
Heart Transplant Program Volume Is Not a Measure of Quality
Surgical Resection of Pulmonary Malignant Tumors After Living Donor Liver Transplantation  Fumihiro Shoji, MD, Daigo Kawano, MD, Toru Ikegami, MD, Yuji.
Michelle C. Wallace, MD, James Jaggers, MD, Jennifer S
Presentation transcript:

Lobar Lung Transplantation: A Relevant Surgical Option in the Current Era of Lung Allocation Score  Norihisa Shigemura, MD, Jonathan D'Cunha, MD, Jay K. Bhama, MD, Akira Shiose, MD, Ashraf Abou El Ela, MD, Amy Hackmann, MD, Diana Zaldonis, MPH, BSN, Yoshiya Toyoda, MD, Joseph M. Pilewski, MD, James D. Luketich, MD, Christian A. Bermudez, MD  The Annals of Thoracic Surgery  Volume 96, Issue 2, Pages 451-456 (August 2013) DOI: 10.1016/j.athoracsur.2013.04.030 Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 The height (inches) distribution of patients with restrictive lung diseases listed for transplant at University of Pittsburgh Medical Center in 2011 and registered donors in our area. Overall 63% of potential recipients were less than 65 inches tall whereas their size-matched donors (less than 60 inches tall) comprised only 8% of all registered local donors. (Yellow = 71 to 75 inches; yellow-green = 66 to 70 inches; green = 61 to 65 inches; blue-green = 56 to 60 inches; red = 51 to 55 inches.) The Annals of Thoracic Surgery 2013 96, 451-456DOI: (10.1016/j.athoracsur.2013.04.030) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions